European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages)

The problems created by supply shortages of medicines have been widely reported and acknowledged at the European level by the European Medicines Agency and European Commission.

Fiche signalétique

  • Département HESB | Santé
  • Pôle de recherche Efficacité et durabilité dans le système de santé
  • Champ de recherche Assessments, interventions, outcomes
  • Organisme de financement COST
    COST
  • Durée 14.04.2016 - 31.10.2018
  • Direction du projet Helena Jenzer
  • Partenaires - établissements de recherche, y c. BFH COST Association
    HESB | Economie, Santé, Travail social
  • Mots-clés medicines shortages, supply chain, bad outcomes (clinical, financial, quality of life)

Contexte initial

The action will find agreements between al stakeholders along the supply chain, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.

But

This Action will encourage systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional products. The Action aims to respond to clinical, financial and quality of life interests.

Compétences clés

all stakeholders along the supply chain (industry, trade, clinics, patients, ethicists, economists, and many more.